Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Brotchie

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Drug News & Perspectives|August 26, 2003
Delta-opioid receptor agonists as a therapeutic approach in Parkinson's diseaseM P Hill, C J Hille, J M Brotchie
Experimental Neurology|January 27, 1999
Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated ratJ E Nash, M P Hill, J M Brotchie
Neuroreport|December 20, 1996
Ionotropic glutamate receptors and nitric oxide synthesis in the rat striatumS J East, A Parry-Jones, J M Brotchie
European Journal of Pharmacology|April 13, 1995
Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomesS J East, M P Hill, J M Brotchie
Experimental Neurology|March 1, 2002
Striatal AMPA receptor binding is unaltered in the MPTP-lesioned macaque model of Parkinson's disease and dyskinesiaM A Silverdale, A R Crossman, J M Brotchie
Experimental Neurology|December 17, 1997
The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's diseaseY P Maneuf, A R Crossman, J M Brotchie
Experimental Neurology|May 30, 1998
Topographical organization of opioid peptide precursor gene expression following repeated apomorphine treatment in the 6-hydroxydopamine-lesioned ratS Duty, B Henry, A R Crossman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 1, 1998
[3H]-2-deoxyglucose uptake study in mutant dystonic hamsters: abnormalities in discrete brain regions of the motor systemA Richter, J M Brotchie, A R Crossman, et al.
Psychopharmacology|May 1, 1995
Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: functional implications for treatment of parkinsonian symptomsC B Carroll, V Holloway, J M Brotchie, et al.
Experimental Neurology|August 25, 2001
Mu- and delta-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's diseaseB Henry, S H Fox, A R Crossman, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Drug News & Perspectives|August 26, 2003
Delta-opioid receptor agonists as a therapeutic approach in Parkinson's diseaseM P Hill, C J Hille, J M Brotchie
Experimental Neurology|January 27, 1999
Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated ratJ E Nash, M P Hill, J M Brotchie
Neuroreport|December 20, 1996
Ionotropic glutamate receptors and nitric oxide synthesis in the rat striatumS J East, A Parry-Jones, J M Brotchie
European Journal of Pharmacology|April 13, 1995
Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomesS J East, M P Hill, J M Brotchie
Experimental Neurology|March 1, 2002
Striatal AMPA receptor binding is unaltered in the MPTP-lesioned macaque model of Parkinson's disease and dyskinesiaM A Silverdale, A R Crossman, J M Brotchie
Experimental Neurology|December 17, 1997
The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's diseaseY P Maneuf, A R Crossman, J M Brotchie
Experimental Neurology|May 30, 1998
Topographical organization of opioid peptide precursor gene expression following repeated apomorphine treatment in the 6-hydroxydopamine-lesioned ratS Duty, B Henry, A R Crossman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 1, 1998
[3H]-2-deoxyglucose uptake study in mutant dystonic hamsters: abnormalities in discrete brain regions of the motor systemA Richter, J M Brotchie, A R Crossman, et al.
Psychopharmacology|May 1, 1995
Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: functional implications for treatment of parkinsonian symptomsC B Carroll, V Holloway, J M Brotchie, et al.
Experimental Neurology|August 25, 2001
Mu- and delta-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's diseaseB Henry, S H Fox, A R Crossman, et al.
Pageof 6